PubMed Trending Research Digest — March 21, 2026
Automated digest · 99 articles · 15 research areas · March 21, 2026
Overview
Recent research trends highlight significant advancements across various medical domains, particularly in cancer therapeutics, cardiovascular health, and metabolic disorders. A substantial number of studies focus on innovative treatment strategies for cancer, including targeted therapies and immunotherapies, which show promise in improving patient outcomes. Additionally, the exploration of metabolic disorders and their implications for conditions like diabetes and obesity is gaining traction, emphasizing the need for integrated approaches to manage these complex health issues.
Moreover, the role of nutrition and dietary interventions is increasingly recognized as a crucial factor in managing chronic diseases, including neurodegenerative disorders and cardiovascular health. The integration of clinical guidelines and recommendations into practice is essential for optimizing patient care, particularly in managing conditions like long COVID and obesity. Overall, the synthesis of these findings underscores the importance of multidisciplinary approaches in advancing healthcare and improving patient outcomes.
Stroke Care and Management
Effect of a clinical decision support system on stroke care quality and outcomes in patients with acute ischaemic stroke (GOLDEN BRIDGE II): cluster randomised clinical trial.
This study evaluated the efficacy of a clinical decision support system (CDSS) on stroke care quality and clinical outcomes among 21,603 patients with acute ischaemic stroke across 77 hospitals in China. The key finding was that the CDSS significantly improved stroke care quality and clinical outcomes compared to standard care. This suggests that implementing CDSS can enhance the management of acute ischaemic stroke, potentially leading to better patient outcomes.
Zhang X, Ding L, Jing J et al. · BMJ (Clinical research ed.) · (2026) · View on PubMed ↗
Cancer Therapeutics
Hijacking ERAD for targeted degradation of transmembrane proteins.
The study focused on developing a targeted protein degradation technology called ERAD-engaging chimeras (ERADECs) to degrade transmembrane proteins, specifically targeting programmed death-ligand 1 (PD-L1). The key finding was that ERADECs effectively degraded PD-L1 by utilizing desonide as a binder for the E3 ligase SYVN1, demonstrating high efficacy in targeting transmembrane proteins. This advancement in TPD technology could have significant implications for drug discovery and therapeutic interventions in diseases involving PD-L1.
Song H, Wang W, Mei T et al. · Cell · (2026) · View on PubMed ↗
USP25 regulates atherosclerosis by restricting RIPK1-mediated inflammatory responses.
This research investigated the role of the deubiquitinating enzyme USP25 in atherosclerosis using mouse models with an ApoE-/- background. The key finding was that USP25 was downregulated in atherosclerotic lesions and its expression in macrophages was crucial for regulating inflammatory responses mediated by RIPK1. This suggests that targeting USP25 could be a novel therapeutic strategy for managing atherosclerosis and its associated inflammatory processes.
Su X, Zhou B, Xu Y et al. · EBioMedicine · (2026) · View on PubMed ↗
Lactylation Converts ABHD6 into a Mitochondrial Regulator that Drives Lenvatinib Resistance in Hepatocellular Carcinoma.
The study examined the role of α/β hydrolase domain containing 6 (ABHD6) in driving resistance to lenvatinib in hepatocellular carcinoma (HCC). The key finding was that lactylation of ABHD6 converted it into a mitochondrial regulator that promotes lenvatinib resistance through non-canonical functions. This highlights the potential of targeting ABHD6 as a therapeutic strategy to overcome resistance in HCC treatment.
Sun Y, Luo C, Yang H et al. · Cancer research · (2026) · View on PubMed ↗
Trends in 5-year net survival for women diagnosed with breast, cervical or ovarian cancer in Japan, 2000-14 (CONCORD-3).
This research analyzed long-term survival trends for women diagnosed with breast, cervical, or ovarian cancer in Japan from 2000 to 2014 using data from the CONCORD-3 study. The key finding was that five-year net survival rates showed significant variations across cancer types and age groups. This highlights the need for targeted interventions to improve cancer outcomes among women in Japan.
Watanabe K, Di Carlo V, Sugiyama H et al. · Japanese journal of clinical oncology · (2026) · View on PubMed ↗
Apoptotic extracellular vesicles derived from MSCs exposed to hypoxic and inflammatory environments slow intervertebral disc degeneration by enhancing cell activity and regulating immunity microenvironment.
This study investigated the therapeutic effects of apoptotic extracellular vesicles (ApoEVs) derived from mesenchymal stem cells (MSCs) in slowing intervertebral disc degeneration (IVDD). The key finding was that ApoEVs enhanced cell activity and regulated the immune microenvironment in the context of IVDD. This suggests that MSC-derived ApoEVs could be a promising therapeutic strategy for treating IVDD.
Zhang W, Ma X, Yin H et al. · Materials today. Bio · (2026) · View on PubMed ↗
Skeletal muscle metabolism in health and disease: Mechanisms, interventions, and clinical perspectives.
This review provided an integrative synthesis of skeletal muscle metabolism, focusing on its role in energy homeostasis and the molecular mechanisms involved. The key finding was that disruptions in metabolic pathways can lead to conditions such as obesity and sarcopenia. This highlights the importance of understanding skeletal muscle metabolism for developing interventions against metabolic diseases.
Lin D, Zhang L, Huang C et al. · iScience · (2026) · View on PubMed ↗
Targeting tumor-associated macrophages-induced IGF1/PI3K/Zic1 axis triggers SHH medulloblastoma regression and chemosensitization.
This study investigated the role of tumor-associated macrophages (TAMs) in medulloblastoma progression and chemoresistance using a genetically modified mouse model. The key finding was that targeting TAMs with specific inhibitors led to tumor regression and increased sensitivity to chemotherapy. This suggests that TAMs could be a viable therapeutic target in treating medulloblastoma.
Pang YC, Wang C, Qiu JF et al. · Neuro-oncology · (2026) · View on PubMed ↗
LRP8 is a functional receptor for yellow fever virus.
This research identified LRP8 as a functional receptor for yellow fever virus (YFV), enhancing our understanding of YFV infection mechanisms. The key finding was that LRP8 expression increased YFV infection in cell lines and exacerbated pathology in mouse models. This discovery could inform vaccine development and therapeutic strategies against YFV.
Mei M, Yang Y, Zhang Z et al. · Nature microbiology · (2026) · View on PubMed ↗
Liquid biopsy for the diagnosis of EBV-positive Burkitt's lymphoma in endemic areas.
This study evaluated the diagnostic accuracy of liquid biopsies for EBV-positive Burkitt's lymphoma in endemic areas of sub-Saharan Africa. The key finding was that blood-based biomarkers, including circulating tumor DNA, improved diagnostic turnaround time and accuracy compared to traditional methods. This suggests that liquid biopsy could enhance early diagnosis and treatment of Burkitt's lymphoma in resource-limited settings.
Chamba C, Christopher H, Josephat E et al. · Nature medicine · (2026) · View on PubMed ↗
Targeting WIP1 reprograms immunosuppressive tumor microenvironment to potentiate immunotherapy response in colorectal cancer.
The study focused on the role of wild-type p53-induced phosphatase 1 (WIP1) in the immunosuppressive tumor microenvironment of colorectal cancer (CRC). It was found that inhibiting WIP1 significantly remodels the tumor immune microenvironment, enhancing anti-tumor immune cell infiltration. This suggests that targeting WIP1 could improve the efficacy of immunotherapy in CRC patients.
Chen L, Chen M, Yuan S et al. · Cell death and differentiation · (2026) · View on PubMed ↗
Type 2 diabetes mellitus.
This article reviewed the epidemiology and clinical implications of type 2 diabetes mellitus (T2DM), particularly its increasing prevalence among younger populations. The key finding indicates that early-onset T2DM is associated with more severe complications and a higher risk factor burden compared to later-onset cases. Understanding these trends is crucial for developing targeted prevention and treatment strategies for T2DM.
Davies MJ, Lim S, Slater T et al. · Nature reviews. Disease primers · (2026) · View on PubMed ↗
Histone lactylation-driven feedback loop modulates pyrimidine metabolism to promote oral carcinogenesis.
This study explored the role of histone lactylation in oral squamous cell carcinoma (OSCC) and its connection to metabolic reprogramming. It was found that lactate-dependent histone modification promotes OSCC initiation through metabolic alterations. This highlights the potential of targeting histone lactylation as a therapeutic strategy in OSCC.
Wang Y, Geng Y, Chen Y et al. · Cell death & disease · (2026) · View on PubMed ↗
Fibrinogen-Bmal1 signaling as a therapeutic target to limit aortic dissection by preserving VSMC contractility.
This study evaluated the therapeutic potential of SHR-A1811, a novel HER2-targeting antibody-drug conjugate, in patients with advanced solid tumors. The trial demonstrated substantial antitumor activity in heavily treated HER2-expressing or mutated tumors. These results support further development of SHR-A1811 as a treatment option for this patient population.
Zhong X, Li D, Zhao Y et al. · Signal transduction and targeted therapy · (2026) · View on PubMed ↗
Prognostic Significance of MSI and EBV Positivity in PD-L1 Positive Gastric Cancer: A Systematic Review and Meta-Analysis.
This systematic review and meta-analysis assessed the prognostic significance of microsatellite instability (MSI), PD-L1 expression, and Epstein-Barr virus (EBV) positivity in gastric cancer. The analysis revealed that these biomarkers are important for predicting overall survival and treatment outcomes in gastric cancer patients. This underscores the need for incorporating these biomarkers into clinical decision-making for gastric cancer management.
Petrelli F, Antista M, Ghidini A et al. · Cancer medicine · (2026) · View on PubMed ↗
Risk Assessment in Large B-Cell Lymphoma Using Metabolic Tumor Volume: Real-World Data from a Multicenter Cohort of Patients Undergoing CAR T-Cell Therapy.
This study evaluated the use of metabolic tumor volume (MTV) as a predictive biomarker for outcomes in patients with large B-cell lymphoma undergoing CAR T-cell therapy. The results indicated that MTV-based risk scores could predict treatment responses more accurately than the traditional International Prognostic Index (IPI). This finding could improve patient stratification and treatment planning in CAR T-cell therapy.
Voltin CA, Flossdorf S, Kurch L et al. · Journal of nuclear medicine : official publication, Society of Nuclear Medicine · (2026) · View on PubMed ↗
Anifrolumab in systemic lupus erythematosus: real-world evidence from a Spanish multicentre cohort of 206 patients and literature review.
This multicenter study assessed the real-world effectiveness and safety of anifrolumab in patients with systemic lupus erythematosus (SLE). The findings indicate that anifrolumab is effective in clinical practice, supporting its use beyond randomized clinical trials. This research contributes to the growing body of evidence for anifrolumab's role in managing SLE.
Calvo-Río V, Secada-Gómez C, Martín Gutiérrez A et al. · RMD open · (2026) · View on PubMed ↗
Hypoxia-related and immune phenotype-related fusion model for non-invasive prognostication of hepatocellular carcinoma treated by TACE: a multicentre study.
This multicenter study developed a hypoxia-related and immune phenotype-related fusion model for prognostication in hepatocellular carcinoma (HCC) patients treated with transarterial chemoembolization (TACE). The model demonstrated improved predictive accuracy for survival outcomes compared to existing prognostic scores. This could enhance clinical decision-making and patient management in HCC.
Guo Y, Zhang G, Fu X et al. · Gut · (2026) · View on PubMed ↗
CAV1-DOT1L axis in TAM-derived EVs orchestrates VM and sensitises PDAC to combined VM and VEGF targeting.
This study investigated the role of the CAV1-DOT1L axis in tumor-associated macrophage-derived extracellular vesicles in promoting vasculogenic mimicry (VM) in pancreatic ductal adenocarcinoma (PDAC). The findings elucidate the immune and epigenetic mechanisms regulating VM, suggesting potential therapeutic targets. This research could inform strategies to combat PDAC progression.
Liu Z, Zhang Y, Wu H et al. · Gut · (2026) · View on PubMed ↗
The efficacy and safety of cannabinoids for the treatment of mental disorders and substance use disorders: a systematic review and meta-analysis.
This systematic review and meta-analysis evaluated the efficacy and safety of cannabinoids for treating mental disorders and substance use disorders. The analysis found that the evidence for cannabinoids as a primary treatment remains inconclusive. This highlights the need for further research to establish clear guidelines for cannabinoid use in these conditions.
Wilson J, Dobson O, Langcake A et al. · The lancet. Psychiatry · (2026) · View on PubMed ↗
A bispecific nanobody-drug conjugate targeting TROP2 and c-Met for low-concentration, single-dose treatment of pancreatic cancer.
This study investigated the efficacy of a bispecific nanobody-drug conjugate (B6ADC) targeting TROP2 and c-Met in pancreatic cancer. B6ADC demonstrated potent cytotoxicity in vitro and superior tumor inhibition in vivo compared to single-target antibody-drug conjugates. This finding suggests that B6ADC could provide a more effective treatment option for pancreatic cancer patients with heterogeneous antigen expression.
Ning W, Liu H, Zeng H et al. · Cell reports. Medicine · (2026) · View on PubMed ↗
Psoriasis modulates inflammatory bowel disease risk and intestinal epithelium lipid metabolism via IL-1β-producing macrophages.
This study examined the relationship between psoriasis and the risk of inflammatory bowel disease (IBD) through the role of IL-1β-producing macrophages. An inverse correlation was found between psoriasis severity and plasma apolipoprotein B48 levels, indicating impaired intestinal lipid handling. These findings suggest that psoriasis may influence IBD risk through alterations in lipid metabolism and immune responses.
Wu J, Liu S, Dan W et al. · Cell metabolism · (2026) · View on PubMed ↗
Preferences in Cyclin-Dependent Kinase 4/6 Inhibitors for Advanced Breast Cancer Among Medical Oncologists in Latin America.
The preferences for cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) among medical oncologists in Latin America were surveyed. Ribociclib emerged as the preferred agent, reflecting its perceived efficacy and availability. Understanding these preferences can inform treatment strategies and improve access to effective therapies for advanced breast cancer in the region.
Villarreal-Garza C, Meraz-Brenez A, Reyes Morales A et al. · JCO global oncology · (2026) · View on PubMed ↗
Efficacy and Safety of Remimazolam Tosylate versus Propofol for Sedation of Postoperative Mechanically Ventilated Patients in Intensive Care Units: a Multicenter, Randomized, Single-blind, Non-inferiority, Phase 3 trial.
A multicenter, randomized, single-blind, phase 3 trial compared the efficacy and safety of remimazolam tosylate versus propofol for sedation in mechanically ventilated ICU patients. Remimazolam tosylate demonstrated non-inferiority to propofol in achieving target sedation levels. This study supports the use of remimazolam tosylate as a viable alternative for sedation in critical care settings.
Guan X, Liu N, Lin F et al. · Anesthesiology · (2026) · View on PubMed ↗
A sympathetic-eosinophil axis orchestrates psychological stress to exacerbate skin inflammation.
The study investigated how a sympathetic-eosinophil axis mediates the exacerbation of skin inflammation due to psychological stress. Specific sympathetic neurons were shown to recruit eosinophils, worsening atopic dermatitis symptoms. This discovery highlights potential targets for therapeutic intervention in stress-related skin disorders.
Tian J, Cao Y, Li Y et al. · Science (New York, N.Y.) · (2026) · View on PubMed ↗
Overcoming T cell tolerance to tumor self-antigens through catch-bond engineering.
The study investigated how catch-bond engineering can overcome T cell tolerance to tumor self-antigens. A modified T cell receptor targeting prostatic acid phosphatase (PAP) showed enhanced activity and tumor elimination in preclinical models. This approach could lead to more effective immunotherapies for cancer treatment.
Chen X, Mao Z, Kolawole EM et al. · Science (New York, N.Y.) · (2026) · View on PubMed ↗
Human DHX29 detects nonoptimal codon usage to regulate mRNA stability.
This research focused on the role of the RNA-binding protein DHX29 in regulating mRNA stability through nonoptimal codon usage. DHX29 was identified as a critical factor in codon-dependent gene expression in human cells. Understanding this mechanism could provide insights into gene regulation and potential therapeutic targets.
Hia F, Wu Y, Yoshinaga M et al. · Science (New York, N.Y.) · (2026) · View on PubMed ↗
A CHKA-PML autophagy checkpoint enables tumors to evade glutamine starvation.
This study investigated the role of choline kinase alpha (CHKA) in tumor cells under glutamine deprivation. The key finding was that CHKA enhances its noncanonical protein kinase activity, leading to the phosphorylation of promyelocytic leukemia (PML) at tyrosine 339, which promotes PML's cytoplasmic localization and alters its function. This research highlights a potential adaptive mechanism that tumors use to evade glutamine starvation, suggesting new therapeutic targets for cancer treatment.
Wang R, Cao L, He X et al. · Proceedings of the National Academy of Sciences of the United States of America · (2026) · View on PubMed ↗
ALG6 orchestrates coronavirus replication via the endoplasmic reticulum stress-autophagy axis.
The study focused on the role of alpha-1,3-glucosyltransferase (ALG6) in the replication of coronaviruses, specifically transmissible gastroenteritis virus (TGEV). It was found that ALG6 knockout (KO) inhibits viral entry by downregulating the receptor aminopeptidase N (ANPEP) and triggers endoplasmic reticulum stress, suppressing viral replication. This research underscores the importance of host factors in coronavirus biology and may inform strategies for antiviral therapies.
Fu Y, Gao M, Fu Z et al. · Cell reports · (2026) · View on PubMed ↗
Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study.
This multicenter, real-world study evaluated the effectiveness and tolerability of ritlecitinib, a selective Janus kinase 3 inhibitor, in patients with severe alopecia areata over 24 weeks. The results indicated significant improvement in hair regrowth and tolerability among patients treated with ritlecitinib. This study contributes valuable real-world evidence supporting the use of ritlecitinib as a treatment option for severe alopecia areata.
Starace M, Rapparini L, Pampaloni F et al. · American journal of clinical dermatology · (2026) · View on PubMed ↗
Post hoc estimation of a quantitative restriction spectrum imaging biomarker for prostate cancer detection using conventional MRI.
The study assessed the potential of restriction spectrum imaging (RSI) as a quantitative biomarker for prostate cancer detection using conventional MRI. It demonstrated that post hoc estimation of RSI metrics from standard diffusion-weighted imaging could serve as a viable surrogate for detecting clinically significant prostate cancer. This advancement may improve diagnostic accuracy in prostate cancer screening.
Do DD, Conlin CC, Bagrodia A et al. · Journal of applied clinical medical physics · (2026) · View on PubMed ↗